Product Information
PAXIL CR 37.5 MG TABLET is a brand product labeled by Apotex Corp., priced at $9.7216 per EA under NDC 60505437903. Its NADAC has been published 78 times since May 13, 2020.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
37.5 mg/1
Manufacturer
Apotex Corp.NDC
60505437903
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020936On Market Since
1/1/2011
Pharmacological Classes
Price Statistics
The NADAC for PAXIL CR 37.5 MG TABLET has been published 78 times since May 13, 2020, and over the history we have for it it has risen 40.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7216 per EA |
|---|---|
| All-time high | $10.4244 (Jun 11, 2025) |
| All-time low | $6.9194 (May 13, 2020) |
| 52-week high | $9.7216 |
| 52-week low | $9.4865 |
| Median price | $10.4244 |
| Average price | $9.9757 |
| Largest weekly change | +36.7% (Apr 17, 2024) |
| Weeks tracked | 78 |
| Tracking since | May 13, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAXIL CR 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAXIL CR 37.5 MG TABLET, manufactured by Apotex Corp., is $9.7216 per EA (NDC 60505437903), effective Oct 1, 2025.
How has the price of PAXIL CR 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAXIL CR 37.5 MG TABLET has risen 40.5%. It has been tracked across 78 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for PAXIL CR 37.5 MG TABLET?
Since May 13, 2020, the NADAC for PAXIL CR 37.5 MG TABLET has ranged from a low of $6.9194 (May 13, 2020) to a high of $10.4244 (Jun 11, 2025), with a median of $10.4244 per EA.
Are there cheaper alternatives to PAXIL CR 37.5 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PAROXETINE CR 37.5 MG TABLET, is $0.4279 per EA — about 96% below PAXIL CR 37.5 MG TABLET.
Who manufactures PAXIL CR 37.5 MG TABLET?
PAXIL CR 37.5 MG TABLET (NDC 60505437903) is labeled by Apotex Corp., and CMS classifies it as a brand product.
Related Drugs
Same classification